Authored by: Remco op den Kelder, Global President of Inizio Advisory
In this Q&A with pharmaphorum, Remco op den Kelder, our Global President of Inizio Advisory, shares his leadership journey and vision for the future of healthcare strategy. Reflecting on over 20 years at Putnam and now leading Inizio’s global advisory offering, Remco discusses the importance of purpose-driven teamwork, the thoughtful integration of AI, and navigating a rapidly evolving pharma landscape. His insights offer a glimpse into the values that shape Inizio Advisory’s work: collaboration, critical thinking, and a deep commitment to improving patient outcomes.
Read the full interview here: pharmaphorum.com
Jump to a slide with the slide dots.
Richard Lawrence
The human factor: Why people make iON.AI matter
There’s a lot of buzz around AI, and for good reason. We’re witnessing a once-in-a-generation shift in how technology supports Medical Affairs.
Read moreStart small: Kelly Malloy’s playbook for modernizing MSL training with GenAI.
At Fierce Pharma Week, Kelly Malloy (Senior Vice President of Customer Engagement for AI and Augmented Intelligence), laid out a pragmatic, evidence-b
Read moreIs ChatGPT a friend or foe to pharma marketers?
The rise of AI tools like ChatGPT, Gemini, and Perplexity is transforming how patients and healthcare professionals search for health information.
Read more